Skip to main content
. Author manuscript; available in PMC: 2021 Feb 22.
Published in final edited form as: J Mol Med (Berl). 2020 Feb 17;98(4):451–467. doi: 10.1007/s00109-020-01887-x

Table 1.

Genetic models used in islet paracrine signaling studies.

Model Target Cre driver Goal Caveats Reference
bTC6-F7 cell IR overexpression insulin receptor N/A gain of function   [45]
bTC6-F7 cell IR kinase dead insulin receptor N/A loss of function   [45]
beta cell specific IR KO insulin receptor Insulin I Cre knockin loss of function   [6062]
BIRKO insulin receptor Rat insulin II promoter loss of function promoter contains hGF minigene deletion in brain [48, 49]
beta IGF-1R KO IGF-1 receptor Rat insulin II promoter loss of function promoter contains hGF minigene deletion in brain [51, 53]
beta double IR IGFR KO IR and IGF-1R Rat insulin II promoter loss of function promoter contains hGF minigene deletion in brain [53]
alpha cell IR KO insulin receptor glucagon promoter loss of function   [6]
delta cell IR KO insulin receptor SST-Cre loss of function not specific to islet delta cells [119]
GcgR null mice GcgR N/A loss of function   [73, 74]
beta cell GcgR KO GcgR Mouse insulin I promoter loss of function promoter contains hGF minigene [83]
beta cell GcgR overexpression GcgR Rat insulin II promoter gain of function promoter contains hGF minigene deletion in brain [66]
GLP-1R null mice GLP-1R N/A loss of function   [83]
SSTR2 null mice SSTR2 N/A loss of function   [116]
SSTR5 null mice SSTR5 N/A loss of function   [126]
SST-Cre;R26-DTA Somatostatin+ cells SST-Cre loss of function   [118]
Ghrelin null mice Ghrl N/A loss of function   [130]
Ghrelin receptor null mice Ghsr N/A loss of function   [130]
ZnT8 null mice Slc30a8 N/A loss of function   [37]